CA2087844A1 - Recepteur de cannabinoide - Google Patents

Recepteur de cannabinoide

Info

Publication number: CA2087844A1
Authority: CA; Canada
Prior art keywords: receptor; cannabinoid receptor; cannabinoid; protein; recombinant
Prior art date: 1990-08-08
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA002087844A

Other languages

English (en)

Inventor

Lisa A. Matsuda

Michael J. Brownstein

Tom I. Bonner

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

United States Department of Commerce

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-08-08

Filing date

1991-08-08

Publication date

1992-02-09

1991-08-08 Application filed by Individual filed Critical Individual

1992-02-09 Publication of CA2087844A1 publication Critical patent/CA2087844A1/fr

Status Abandoned legal-status Critical Current

Links

108050007331 Cannabinoid receptor Proteins 0.000 title claims abstract description 53
102000018208 Cannabinoid Receptor Human genes 0.000 title claims abstract description 51
108020003175 receptors Proteins 0.000 claims abstract description 43
102000005962 receptors Human genes 0.000 claims abstract description 42
108020004414 DNA Proteins 0.000 claims abstract description 30
108090000623 proteins and genes Proteins 0.000 claims abstract description 18
102000004169 proteins and genes Human genes 0.000 claims abstract description 17
102000053602 DNA Human genes 0.000 claims abstract description 10
108020004511 Recombinant DNA Proteins 0.000 claims abstract description 9
210000004027 cell Anatomy 0.000 claims description 52
238000000034 method Methods 0.000 claims description 24
239000003557 cannabinoid Substances 0.000 claims description 19
229930003827 cannabinoid Natural products 0.000 claims description 18
150000001875 compounds Chemical class 0.000 claims description 13
229940065144 cannabinoids Drugs 0.000 claims description 12
210000001519 tissue Anatomy 0.000 claims description 12
239000002299 complementary DNA Substances 0.000 claims description 11
239000012472 biological sample Substances 0.000 claims description 10
239000012634 fragment Substances 0.000 claims description 9
230000000295 complement effect Effects 0.000 claims description 8
239000013598 vector Substances 0.000 claims description 8
238000003556 assay Methods 0.000 claims description 6
108020004635 Complementary DNA Proteins 0.000 claims description 4
238000001514 detection method Methods 0.000 claims description 4
238000012216 screening Methods 0.000 claims description 4
238000010804 cDNA synthesis Methods 0.000 claims description 3
108091028664 Ribonucleotide Proteins 0.000 claims description 2
239000008280 blood Substances 0.000 claims description 2
210000004369 blood Anatomy 0.000 claims description 2
210000001175 cerebrospinal fluid Anatomy 0.000 claims description 2
-1 cerebrospinal fluid Substances 0.000 claims description 2
238000012258 culturing Methods 0.000 claims description 2
239000013604 expression vector Substances 0.000 claims description 2
239000000284 extract Substances 0.000 claims description 2
239000002336 ribonucleotide Substances 0.000 claims description 2
125000002652 ribonucleotide group Chemical group 0.000 claims description 2
210000002700 urine Anatomy 0.000 claims description 2
125000003275 alpha amino acid group Chemical group 0.000 claims 3
241000124008 Mammalia Species 0.000 claims 2
101710120271 Bone morphogenetic protein receptor type-1B Proteins 0.000 description 25
150000001413 amino acids Chemical group 0.000 description 18
OHCQJHSOBUTRHG-KGGHGJDLSA-N FORSKOLIN Chemical compound O=C([C@@]12O)C[C@](C)(C=C)O[C@]1(C)[C@@H](OC(=O)C)[C@@H](O)[C@@H]1[C@]2(C)[C@@H](O)CCC1(C)C OHCQJHSOBUTRHG-KGGHGJDLSA-N 0.000 description 16
241000700159 Rattus Species 0.000 description 12
230000000694 effects Effects 0.000 description 9
108020004999 messenger RNA Proteins 0.000 description 9
235000018102 proteins Nutrition 0.000 description 9
239000000523 sample Substances 0.000 description 9
SUZLHDUTVMZSEV-UHFFFAOYSA-N Deoxycoleonol Natural products C12C(=O)CC(C)(C=C)OC2(C)C(OC(=O)C)C(O)C2C1(C)C(O)CCC2(C)C SUZLHDUTVMZSEV-UHFFFAOYSA-N 0.000 description 8
OHCQJHSOBUTRHG-UHFFFAOYSA-N colforsin Natural products OC12C(=O)CC(C)(C=C)OC1(C)C(OC(=O)C)C(O)C1C2(C)C(O)CCC1(C)C OHCQJHSOBUTRHG-UHFFFAOYSA-N 0.000 description 8
239000003814 drug Substances 0.000 description 7
230000001593 cAMP accumulation Effects 0.000 description 6
229940079593 drug Drugs 0.000 description 6
239000003446 ligand Substances 0.000 description 6
YNZFFALZMRAPHQ-SYYKKAFVSA-N 2-[(1r,2r,5r)-5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]-5-(2-methyloctan-2-yl)phenol Chemical compound OC1=CC(C(C)(C)CCCCCC)=CC=C1[C@H]1[C@H](CCCO)CC[C@@H](O)C1 YNZFFALZMRAPHQ-SYYKKAFVSA-N 0.000 description 5
102000014415 Muscarinic acetylcholine receptor Human genes 0.000 description 5
108050003473 Muscarinic acetylcholine receptor Proteins 0.000 description 5
210000003710 cerebral cortex Anatomy 0.000 description 5
230000002209 hydrophobic effect Effects 0.000 description 5
230000003551 muscarinic effect Effects 0.000 description 5
239000002773 nucleotide Substances 0.000 description 5
125000003729 nucleotide group Chemical group 0.000 description 5
108090000765 processed proteins & peptides Proteins 0.000 description 5
108091032973 (ribonucleotides)n+m Proteins 0.000 description 4
108010040722 Neurokinin-2 Receptors Proteins 0.000 description 4
102100037342 Substance-K receptor Human genes 0.000 description 4
239000000556 agonist Substances 0.000 description 4
235000001014 amino acid Nutrition 0.000 description 4
230000000875 corresponding effect Effects 0.000 description 4
230000005764 inhibitory process Effects 0.000 description 4
238000002360 preparation method Methods 0.000 description 4
244000025254 Cannabis sativa Species 0.000 description 3
GJSURZIOUXUGAL-UHFFFAOYSA-N Clonidine Chemical compound ClC1=CC=CC(Cl)=C1NC1=NCCN1 GJSURZIOUXUGAL-UHFFFAOYSA-N 0.000 description 3
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
238000000636 Northern blotting Methods 0.000 description 3
239000005557 antagonist Substances 0.000 description 3
229960002896 clonidine Drugs 0.000 description 3
238000002474 experimental method Methods 0.000 description 3
102000004196 processed proteins & peptides Human genes 0.000 description 3
102000040650 (ribonucleotides)n+m Human genes 0.000 description 2
108060003345 Adrenergic Receptor Proteins 0.000 description 2
102000017910 Adrenergic receptor Human genes 0.000 description 2
235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 2
235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 2
208000010412 Glaucoma Diseases 0.000 description 2
230000004988 N-glycosylation Effects 0.000 description 2
206010029260 Neuroblastoma Diseases 0.000 description 2
208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
230000035508 accumulation Effects 0.000 description 2
238000009825 accumulation Methods 0.000 description 2
230000009471 action Effects 0.000 description 2
238000004458 analytical method Methods 0.000 description 2
208000006673 asthma Diseases 0.000 description 2
210000004556 brain Anatomy 0.000 description 2
230000003491 cAMP production Effects 0.000 description 2
238000002512 chemotherapy Methods 0.000 description 2
238000010367 cloning Methods 0.000 description 2
235000018417 cysteine Nutrition 0.000 description 2
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
210000001947 dentate gyrus Anatomy 0.000 description 2
231100000673 dose–response relationship Toxicity 0.000 description 2
230000013595 glycosylation Effects 0.000 description 2
238000006206 glycosylation reaction Methods 0.000 description 2
210000001320 hippocampus Anatomy 0.000 description 2
238000009396 hybridization Methods 0.000 description 2
208000030603 inherited susceptibility to asthma Diseases 0.000 description 2
206010022437 insomnia Diseases 0.000 description 2
230000003993 interaction Effects 0.000 description 2
238000002955 isolation Methods 0.000 description 2
230000004807 localization Effects 0.000 description 2
GECBBEABIDMGGL-RTBURBONSA-N nabilone Chemical compound C1C(=O)CC[C@H]2C(C)(C)OC3=CC(C(C)(C)CCCCCC)=CC(O)=C3[C@@H]21 GECBBEABIDMGGL-RTBURBONSA-N 0.000 description 2
229960002967 nabilone Drugs 0.000 description 2
230000004044 response Effects 0.000 description 2
230000000707 stereoselective effect Effects 0.000 description 2
238000012360 testing method Methods 0.000 description 2
210000000575 ventromedial hypothalamic nucleus Anatomy 0.000 description 2
NCYCYZXNIZJOKI-IOUUIBBYSA-N 11-cis-retinal Chemical compound O=C/C=C(\C)/C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-IOUUIBBYSA-N 0.000 description 1
MJQHZNBUODTQTK-UHFFFAOYSA-N 2-[[3-[2-[(3,4-dihydroxy-2,6-dioxabicyclo[3.2.1]octan-8-yl)oxy]-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-4-hydroxy-2,6-dioxabicyclo[3.2.1]octan-8-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound OC1C(O)C(O)C(CO)OC1OC1C2OCC1OC(OC1C(C(OC3C4OCC3OC(O)C4O)OC(CO)C1O)O)C2O MJQHZNBUODTQTK-UHFFFAOYSA-N 0.000 description 1
102000008873 Angiotensin II receptor Human genes 0.000 description 1
108050000824 Angiotensin II receptor Proteins 0.000 description 1
102400000967 Bradykinin Human genes 0.000 description 1
101800004538 Bradykinin Proteins 0.000 description 1
UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
102100025841 Cholecystokinin Human genes 0.000 description 1
101800001982 Cholecystokinin Proteins 0.000 description 1
208000030814 Eating disease Diseases 0.000 description 1
241000588724 Escherichia coli Species 0.000 description 1
208000019454 Feeding and Eating disease Diseases 0.000 description 1
108091006027 G proteins Proteins 0.000 description 1
102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 1
108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 1
101150066516 GST gene Proteins 0.000 description 1
102000030782 GTP binding Human genes 0.000 description 1
108091000058 GTP-Binding Proteins 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
208000032612 Glial tumor Diseases 0.000 description 1
206010018338 Glioma Diseases 0.000 description 1
QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 description 1
102400001103 Neurotensin Human genes 0.000 description 1
101800001814 Neurotensin Proteins 0.000 description 1
108090000590 Neurotransmitter Receptors Proteins 0.000 description 1
102000004108 Neurotransmitter Receptors Human genes 0.000 description 1
239000000020 Nitrocellulose Substances 0.000 description 1
108091028043 Nucleic acid sequence Proteins 0.000 description 1
108020005187 Oligonucleotide Probes Proteins 0.000 description 1
108700026244 Open Reading Frames Proteins 0.000 description 1
102000016979 Other receptors Human genes 0.000 description 1
102000007079 Peptide Fragments Human genes 0.000 description 1
108010033276 Peptide Fragments Proteins 0.000 description 1
ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
239000013614 RNA sample Substances 0.000 description 1
241000700157 Rattus norvegicus Species 0.000 description 1
102100040756 Rhodopsin Human genes 0.000 description 1
108090000820 Rhodopsin Proteins 0.000 description 1
241000235070 Saccharomyces Species 0.000 description 1
240000004808 Saccharomyces cerevisiae Species 0.000 description 1
108020004682 Single-Stranded DNA Proteins 0.000 description 1
108010056088 Somatostatin Proteins 0.000 description 1
102000005157 Somatostatin Human genes 0.000 description 1
241000256251 Spodoptera frugiperda Species 0.000 description 1
208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 description 1
206010042297 Subacute sclerosing panencephalitis Diseases 0.000 description 1
108010003205 Vasoactive Intestinal Peptide Proteins 0.000 description 1
102400000015 Vasoactive intestinal peptide Human genes 0.000 description 1
239000002253 acid Substances 0.000 description 1
150000003838 adenosines Chemical class 0.000 description 1
102000030621 adenylate cyclase Human genes 0.000 description 1
108060000200 adenylate cyclase Proteins 0.000 description 1
230000001800 adrenalinergic effect Effects 0.000 description 1
238000011166 aliquoting Methods 0.000 description 1
229940035676 analgesics Drugs 0.000 description 1
238000010171 animal model Methods 0.000 description 1
239000000730 antalgic agent Substances 0.000 description 1
229940125681 anticonvulsant agent Drugs 0.000 description 1
239000001961 anticonvulsive agent Substances 0.000 description 1
230000000386 athletic effect Effects 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
210000001124 body fluid Anatomy 0.000 description 1
239000010839 body fluid Substances 0.000 description 1
QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 description 1
210000005013 brain tissue Anatomy 0.000 description 1
239000001110 calcium chloride Substances 0.000 description 1
229910001628 calcium chloride Inorganic materials 0.000 description 1
235000011148 calcium chloride Nutrition 0.000 description 1
AIXAANGOTKPUOY-UHFFFAOYSA-N carbachol Chemical compound [Cl-].C[N+](C)(C)CCOC(N)=O AIXAANGOTKPUOY-UHFFFAOYSA-N 0.000 description 1
229960004484 carbachol Drugs 0.000 description 1
210000003169 central nervous system Anatomy 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
210000004978 chinese hamster ovary cell Anatomy 0.000 description 1
229940107137 cholecystokinin Drugs 0.000 description 1
230000019771 cognition Effects 0.000 description 1
239000000470 constituent Substances 0.000 description 1
210000004748 cultured cell Anatomy 0.000 description 1
125000004122 cyclic group Chemical group 0.000 description 1
125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
230000007812 deficiency Effects 0.000 description 1
235000014113 dietary fatty acids Nutrition 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000012895 dilution Substances 0.000 description 1
235000014632 disordered eating Nutrition 0.000 description 1
238000009826 distribution Methods 0.000 description 1
238000003255 drug test Methods 0.000 description 1
238000001962 electrophoresis Methods 0.000 description 1
210000003527 eukaryotic cell Anatomy 0.000 description 1
229930195729 fatty acid Natural products 0.000 description 1
239000000194 fatty acid Substances 0.000 description 1
150000004665 fatty acids Chemical class 0.000 description 1
ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
230000004927 fusion Effects 0.000 description 1
239000000499 gel Substances 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
239000001963 growth medium Substances 0.000 description 1
ZJYYHGLJYGJLLN-UHFFFAOYSA-N guanidinium thiocyanate Chemical compound SC#N.NC(N)=N ZJYYHGLJYGJLLN-UHFFFAOYSA-N 0.000 description 1
UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical class O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 1
230000000971 hippocampal effect Effects 0.000 description 1
229940088597 hormone Drugs 0.000 description 1
239000005556 hormone Substances 0.000 description 1
210000004754 hybrid cell Anatomy 0.000 description 1
238000007901 in situ hybridization Methods 0.000 description 1
VBUWHHLIZKOSMS-RIWXPGAOSA-N invicorp Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=C(O)C=C1 VBUWHHLIZKOSMS-RIWXPGAOSA-N 0.000 description 1
210000004072 lung Anatomy 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
230000010534 mechanism of action Effects 0.000 description 1
239000012528 membrane Substances 0.000 description 1
230000015654 memory Effects 0.000 description 1
CWWARWOPSKGELM-SARDKLJWSA-N methyl (2s)-2-[[(2s)-2-[[2-[[(2s)-2-[[(2s)-2-[[(2s)-5-amino-2-[[(2s)-5-amino-2-[[(2s)-1-[(2s)-6-amino-2-[[(2s)-1-[(2s)-2-amino-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-5 Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)OC)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CCCN=C(N)N)C1=CC=CC=C1 CWWARWOPSKGELM-SARDKLJWSA-N 0.000 description 1
230000036651 mood Effects 0.000 description 1
229940035363 muscle relaxants Drugs 0.000 description 1
239000003158 myorelaxant agent Substances 0.000 description 1
PCJGZPGTCUMMOT-ISULXFBGSA-N neurotensin Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 PCJGZPGTCUMMOT-ISULXFBGSA-N 0.000 description 1
239000002858 neurotransmitter agent Substances 0.000 description 1
239000002547 new drug Substances 0.000 description 1
229920001220 nitrocellulos Polymers 0.000 description 1
108091027963 non-coding RNA Proteins 0.000 description 1
102000042567 non-coding RNA Human genes 0.000 description 1
239000002751 oligonucleotide probe Substances 0.000 description 1
230000008447 perception Effects 0.000 description 1
229920001184 polypeptide Polymers 0.000 description 1
230000003334 potential effect Effects 0.000 description 1
210000001236 prokaryotic cell Anatomy 0.000 description 1
125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
238000000159 protein binding assay Methods 0.000 description 1
238000001742 protein purification Methods 0.000 description 1
230000001105 regulatory effect Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
230000028327 secretion Effects 0.000 description 1
238000012163 sequencing technique Methods 0.000 description 1
IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 1
NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 description 1
229960000553 somatostatin Drugs 0.000 description 1
241000894007 species Species 0.000 description 1
238000010561 standard procedure Methods 0.000 description 1
239000000126 substance Substances 0.000 description 1
238000006467 substitution reaction Methods 0.000 description 1
239000000725 suspension Substances 0.000 description 1
229940124597 therapeutic agent Drugs 0.000 description 1
238000001890 transfection Methods 0.000 description 1
241000701447 unidentified baculovirus Species 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Neurosurgery (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Toxicology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Cell Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Gastroenterology & Hepatology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Rectifiers (AREA)
Pyrane Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

CA002087844A 1990-08-08 1991-08-08 Recepteur de cannabinoide Abandoned CA2087844A1 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US56407590A	1990-08-08	1990-08-08
US564,075		1990-08-08

Publications (1)

Publication Number	Publication Date
CA2087844A1 true CA2087844A1 (fr)	1992-02-09

Family

ID=24253065

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002087844A Abandoned CA2087844A1 (fr)	1990-08-08	1991-08-08	Recepteur de cannabinoide

Country Status (5)

Country	Link
EP (1)	EP0542920A4 (fr)
JP (1)	JPH05507417A (fr)
AU (1)	AU645609B2 (fr)
CA (1)	CA2087844A1 (fr)
WO (1)	WO1992002640A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU6573794A (en) *	1993-04-27	1994-11-21	Medical Research Council	Cannabinoid receptor expressed in cells of the immune system
FR2714580B1 (fr) *	1993-12-30	1996-02-09	Seb Sa	Accessoire de coiffure pour appareil à sécher les cheveux.
CN1315437A (zh) *	2000-03-29	2001-10-03	上海博德基因开发有限公司	一种新的多肽——人大麻醇受体蛋白19和编码这种多肽的多核苷酸
CN1323822A (zh) *	2000-05-16	2001-11-28	上海博德基因开发有限公司	一种新的多肽——人中枢大麻成分受体22和编码这种多肽的多核苷酸
SE0202240D0 (sv) *	2002-07-17	2002-07-17	Astrazeneca Ab	Genes
SE0202242D0 (sv) *	2002-07-17	2002-07-17	Astrazeneca Ab	Compounds
EP2722669A1 (fr)	2012-10-22	2014-04-23	Securetec Detektions-Systeme AG	Procédé et dispositif destinés à la vérification de drogues illégales
WO2020232350A1 (fr) *	2019-05-15	2020-11-19	The Regents Of The University Of Colorado, A Body Corporate	Dosages pour cannabinoïdes synthétiques
CN119585311A (zh) *	2022-07-28	2025-03-07	长春金赛药业有限责任公司	结合大麻素受体cb1的抗体及其用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH01273582A (ja) *	1988-04-26	1989-11-01	Matsushita Electric Ind Co Ltd	モノクローナル抗体産生細胞ライン及びモノクローナル抗体及び免疫原
JPH068399B2 (ja) *	1988-08-10	1994-02-02	東洋製罐株式会社	製缶用塗料
JPH0257178A (ja) *	1988-08-22	1990-02-26	Matsushita Electric Ind Co Ltd	モノクローナル抗体産生細胞ラインおよびモノクローナル抗体

1991
- 1991-08-08 CA CA002087844A patent/CA2087844A1/fr not_active Abandoned
- 1991-08-08 WO PCT/US1991/005656 patent/WO1992002640A1/fr not_active Ceased
- 1991-08-08 AU AU85430/91A patent/AU645609B2/en not_active Ceased
- 1991-08-08 EP EP19910917229 patent/EP0542920A4/en not_active Withdrawn
- 1991-08-08 JP JP91515626A patent/JPH05507417A/ja active Pending

Also Published As

Publication number	Publication date
EP0542920A4 (en)	1993-07-14
AU8543091A (en)	1992-03-02
AU645609B2 (en)	1994-01-20
EP0542920A1 (fr)	1993-05-26
JPH05507417A (ja)	1993-10-28
WO1992002640A1 (fr)	1992-02-20

Publication	Publication Date	Title
CA2071879C (fr)	2007-05-15	Compositions et methodes pour le recepteur du glutamate
Shapiro et al.	1989	Characterization and functional expression in mammalian cells of genomic and cDNA clones encoding a Drosophila muscarinic acetylcholine receptor.
JP4216326B2 (ja)	2009-01-28	ヒト神経ペプチドｙ／ペプチドｙｙ／膵臓ポリペプチド受容体（ｙ４）をコードしたｄｎａ、及び該ｄｎａの使用
AU694424B2 (en)	1998-07-23	Human neuronal nicotinic acetylcholine receptor compositionsand methods employing same
Nash et al.	1993	Cloning and characterization of the opossum kidney cell D1 dopamine receptor: expression of identical D1A and D1B dopamine receptor mRNAs in opossum kidney and brain.
WO1994028131A1 (fr)	1994-12-08	Adn codant des canaux potassiques kga actives par la proteine g et servant de regulateurs internes chez les mammiferes, et son utilisation
CA2087844A1 (fr)	1992-02-09	Recepteur de cannabinoide
Duman et al.	1989	Development of β-adrenergic receptor and G protein messenger RNA in rat brain
US7510846B2 (en)	2009-03-31	Assay employing human or rat GAL-R2 galanin receptor
US5789196A (en)	1998-08-04	Recombinantly produced β4 neuronal nicotinic acetylcholine receptor subunits
US20090226436A1 (en)	2009-09-10	Novel receptors
WO2002042458A2 (fr)	2002-05-30	Nouveaux recepteurs
WO2002000719A2 (fr)	2002-01-03	Nouveaux recepteurs
Miotto et al.	1995	Molecular characterization of opioid receptors
US6576742B1 (en)	2003-06-10	DNA sequence encoding a human imidazoline receptor and method for cloning the same
WO2001068704A2 (fr)	2001-09-20	Recepteurs couples a la proteine g
AU2001245675A1 (en)	2001-12-06	G-protein coupled receptors
Stadel et al.	1991	Molecular Biology of ẞ-Adrenoceptors
US6635741B1 (en)	2003-10-21	G-protein coupled receptor BCA-GPCR-3
US5945509A (en)	1999-08-31	Glutamate receptor compositions and method
US20020111473A1 (en)	2002-08-15	Novel g protein coupled receptor
Robinson et al.	2013	Interactions of Dopamine Receptors
US20030139589A1 (en)	2003-07-24	G protein coupled receptor A4
CA2284857A1 (fr)	2000-04-16	Recepteur a4 couple a une proteine g

Legal Events

Date	Code	Title	Description
1993-01-21	EEER	Examination request
1996-02-08	FZDE	Dead